-
平臺編號：bio-49447
-
國際編號：ATCC VR-2047
-
拉丁屬名： Vaccinia virus
-
規(guī)格：frozen
-
用途：ATCC原裝進口
-
服務(wù)費用：
加載中…… - 訂購
-
注意事項：僅用于科學(xué)研究或者工業(yè)應(yīng)用等非醫(yī)療目的不可用于人類或動物的臨床診斷或治療，非藥用，非食用（產(chǎn)品信息以出庫為準）
Vaccinia virus
ATCC? Number:VR-2047?
Classification: Poxviridae, Orthopoxvirus
Agent: Vaccinia virus
Strain: vP-13
Depositors: E Paoletti
Biosafety Level:2
Shipped: frozen
Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Host Organism : HeLa cells (ATCCCCL-2); CV-1 (ATCCCCL-70); Vero (ATCCCCL-81); chicken embryo fibroblast
Effect : Yes, in vitro effects: Cytopathic effects in tissue culture
Comments : Recombinant vaccinia containing the Hhal hepatitis B fragment coding for HBV surface antigen. A HhaI fragment encoding HBsAg was cloned into vP-8 (ATCCVR-2053) by in vivo recombination. No expression of the insert has been detected. [13130]
References : 13123: Paoletti E, Panicali D. Modified vaccinia virus. US Patent 4,603,112 dated Jul 29 1986 13130: Paoletti E, Panicali D. Method for immunizing animals with synthetically modified vaccinia virus. US Patent 4,722,848 dated Feb 2 1988 13139: Panicali D, et al. Two major DNA variants present in serially propagated stocks of the WR strain of vaccinia virus. J. Virol. 37: 1000-1010, 1981. PubMed: 6262520 32606: Hammon WM, et al. Isolation and characterization of prototype viruses ECHO-26, ECHO-27, Coxsackie B-6. Proc. Soc. Exp. Biol. Med. 103: 164-168, 1960. PubMed: 14399342
Classification: Poxviridae, Orthopoxvirus
Agent: Vaccinia virus
Strain: vP-13
Depositors: E Paoletti
Biosafety Level:2
Shipped: frozen
Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Host Organism : HeLa cells (ATCCCCL-2); CV-1 (ATCCCCL-70); Vero (ATCCCCL-81); chicken embryo fibroblast
Effect : Yes, in vitro effects: Cytopathic effects in tissue culture
Comments : Recombinant vaccinia containing the Hhal hepatitis B fragment coding for HBV surface antigen. A HhaI fragment encoding HBsAg was cloned into vP-8 (ATCCVR-2053) by in vivo recombination. No expression of the insert has been detected. [13130]
References : 13123: Paoletti E, Panicali D. Modified vaccinia virus. US Patent 4,603,112 dated Jul 29 1986 13130: Paoletti E, Panicali D. Method for immunizing animals with synthetically modified vaccinia virus. US Patent 4,722,848 dated Feb 2 1988 13139: Panicali D, et al. Two major DNA variants present in serially propagated stocks of the WR strain of vaccinia virus. J. Virol. 37: 1000-1010, 1981. PubMed: 6262520 32606: Hammon WM, et al. Isolation and characterization of prototype viruses ECHO-26, ECHO-27, Coxsackie B-6. Proc. Soc. Exp. Biol. Med. 103: 164-168, 1960. PubMed: 14399342
